“Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma: The Evolving Canadian Landscape”. 2023. Canadian Hematology Today 2 (3): 33-38. https://doi.org/10.58931/cht.2023.2342.